Capvizr
THE DEAL, AT A GLANCE

πŸ‡©πŸ‡° Biograil

From the announcement
01Who is involvedBacked by Verve Ventures, Megatrend InvestFrom the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement β†—
02What happenedπŸ‡©πŸ‡° Biograil raised announced 2026-11-04From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement β†—
03Why it mattersBiograil's reported €20 million financing round directs capital toward preparations for clinical trials.From the announcement

Summarized from the deal record's source announcement; not yet independently reviewed.

Read the announcement β†—
Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source β†—

πŸ‡©πŸ‡° Biograil Β· Financing Record

Explore source-linked visual explanations for πŸ‡©πŸ‡° Biograil. Unsupported claims are withheld while source review continues.

Record 15399 Β· Recorded date: 2026-11-04

What it does

πŸ‡©πŸ‡° Biograil: illustrative category image
Illustrative image (biotech lab), not πŸ‡©πŸ‡° Biograil's product Β· MatasNavickas / CC BY-SA 4.0

Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.

Open record 15399 β†’

Explore company records β†’
Free weekday briefing

Know which funding rounds matter before the first call.

Source-linked rounds, lead investors, and the signal behind the capital. One five-minute read.

Free Β· Unsubscribe anytime